Envista Holdings Corp
NYSE:NVST
Relative Value
The Relative Value of one NVST stock under the Base Case scenario is 41.24 USD. Compared to the current market price of 19.68 USD, Envista Holdings Corp is Undervalued by 52%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
NVST Competitors Multiples
Envista Holdings Corp Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
E
|
Envista Holdings Corp
NYSE:NVST
|
3.4B USD | 1.3 | -33.7 | 8.3 | 11.8 | |
US |
Abbott Laboratories
NYSE:ABT
|
185B USD | 4.6 | 32.9 | 19.4 | 28.8 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
132.2B USD | 18.1 | 66.5 | 54.5 | 68.4 | ||
US |
Stryker Corp
NYSE:SYK
|
123.9B USD | 6 | 39.1 | 24.5 | 30.2 | ||
IE |
Medtronic PLC
NYSE:MDT
|
108B USD | 3.3 | 25.7 | 13.7 | 19.4 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 7.4 | 67.3 | 31.3 | 46.7 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.6B USD | 3.5 | 55.5 | 18.6 | 39.3 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.1B EUR | 2.7 | 38.3 | 18.4 | 31 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
50.7B USD | 8.4 | 36.1 | 26.1 | 28.3 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
49B USD | 13.5 | 90.5 | 61 | 79.4 |